Cyclosporine A induces senescence in renal tubular epithelial cells

Paul Jennings1, Christian Koppelstaetter, Sonia Aydin

  • 1Division of Physiology, Department of Physiology and Medical Physics, Innsbruck Medical University, Innsbruck, Austria.

Insights

Cyclosporine A (CsA) induces cellular senescence in human kidney tubule cells by increasing oxidative stress. Scavenging reactive oxygen species can prevent this CsA-induced senescence, offering potential therapeutic avenues.

Area of Science:

  • Nephrology
  • Cell Biology
  • Toxicology

Background:

  • Cyclosporine A (CsA) is a vital immunosuppressant with known nephrotoxic effects.
  • The precise mechanisms underlying CsA-induced renal tubular toxicity remain unclear.
  • Shared features between CsA nephropathy and kidney aging suggest a role for cellular senescence.

Purpose of the Study:

  • To investigate whether CsA induces a stress-induced senescent phenotype in renal tubular cells.
  • To elucidate the role of reactive oxygen species (ROS) in CsA-mediated cellular senescence.
  • To explore potential interventions for CsA-induced nephrotoxicity.

Main Methods:

  • In vitro studies using HK-2 cells and primary human proximal tubular cells.
  • Assessment of CsA effects on hydrogen peroxide (H2O2) production, cell cycle progression, and DNA synthesis.
  • Analysis of telomere length, p53 phosphorylation, and expression of senescence markers (p21, p16).
  • Evaluation of the impact of catalase (ROS scavenger) on CsA-treated cells.

Main Results:

  • CsA induced H2O2 production, G0/G1 cell cycle arrest, and inhibited DNA synthesis.
  • CsA exposure led to telomere shortening, increased p53 phosphorylation, and elevated p21(Kip1) mRNA.
  • Primary proximal tubular cells showed increased p16(INK4a) expression after prolonged CsA exposure.
  • Catalase treatment prevented telomere shortening and partially restored DNA synthesis in CsA-exposed cells.

Conclusions:

  • CsA induces cellular senescence in human renal tubular epithelial cells.
  • Oxidative stress plays a critical role in CsA-induced senescence.
  • Targeting ROS may offer a strategy to mitigate CsA nephrotoxicity.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...